BrightSpring’s Commitment to Clinical Quality & Innovation
BrightSpring Health Services has evolved from building a measurement framework into a research-driven organization that validates care innovations with published evidence, demonstrates measurable patient outcomes, and scales successful programs across a national healthcare platform. Our research portfolio now supports care models across home health, pharmacy, primary care, and rehabilitation services.
Read Our Latest White Papers
White Paper: Ambulatory Infusion Therapy in the United States
Ambulatory infusion therapy is an increasingly important healthcare delivery model because it can provide high-quality infusion care in non-hospital settings while improving patient convenience and reducing overall healthcare costs.
White Paper: Innovation and Person-Centered Culture Drives Solutions
BrightSpring presents its experience as evidence that combining research, integrated care delivery, and an organizational culture focused on empathy can improve patient outcomes while supporting broader healthcare system goals.
White Paper: Quality, Innovation, and Intensive Caring at End of Life
BrightSpring presents its experience as evidence that combining research, integrated care delivery, and an organizational culture focused on empathy can improve patient outcomes while supporting broader healthcare system goals.
The Initiative Began in 2019
BrightSpring created a research-driven quality improvement model based on continuous measurement, publication, and scaling of successful programs.
Key accomplishments include:
- 12 peer-reviewed studies published since 2020
- 30+ abstracts, symposia, and scientific presentations between 2020-2025
- 123+ citations in the medical literature
Major milestones highlighted:
- 2019: Established an enterprise outcomes framework and value-based care metrics
- 2020: COVID response studies and introduction of the “Days Spent at Home” metric
- 2022: Home-based primary care for individuals with IDD showed 47% lower hospitalization rates
- 2023-2024: Continue CareRx medication management program associated with a 73% reduction in hospitalizations
Published Studies Produced Measurable Patient Impact
BrightSpring’s programs generated measurable improvements in clinical outcomes, not just quality metrics.
- Patient Safety / COVID Response
- Infection rates remained less than one-third of the U.S. general population during COVID
- Pharmacist interventions reduced hydroxychloroquine use by more than 80% within two weeks
- Home-Based Care
- 47% lower hospitalization rates (329 vs. 619 hospitalizations per 1,000 patient-years)
- Patients spent 98.5% of days at home, approximately 360 days annually
- Continue CareRx
- 73% reduction in hospitalizations through home-based medication management
- Hospitalization rates decreased from 1,203 to 324 per 1,000 patient years
- Vitality Therapy
- Short Physical Performance Battery scores improved from 4.3 to 9.0 (+4.7 points)
- Clinical Frailty Scale improved from 5.7 to 4.4, indicating greater independence
Research Embedded in Operations at National Scale
The BrightSpring innovation cycle integrates research into daily operations. The model consists of four steps:
- Identify care gaps using outcomes data
- Build and test solutions through operational pilots
- Publish and present findings to clinicians, payers, and policymakers
- Scale successful programs and use lessons learned to drive further innovation
Current-scale proof points include:
- 400,000+ people served daily
- Operations in all 50 states
- 91.4% of home health branches rated 4+ stars (vs. national benchmark ~70-75%)
- 76% hospice visits in the last three days of life (vs. national benchmark 48.3%)
- 92.4% specialty pharmacy medication possession ratio (above CMS adherence threshold of 80%)
- 40-50 person AI team focused on predictive alerts, workflow optimization, scheduling efficiency, and remote patient monitoring